Stellar Blue

Jay Runyon

Writer specializing in primary care, public health and healthcare quality, translating clinical research and policy into writing that clinicians and patients actually use. Designer of handmade brochures, logos and print materials.

For nearly 20 years, Jay Runyon has translated dense clinical research, public health data and quality-improvement science into writing that primary care physicians, care teams and patients can put to use. Along the way she has carried titles beyond "writer" (project facilitator, program manager and practice transformation lead), and that operational background shows up in the writing itself: an instinct for what a clinician needs to know to act, not just to read.

"Writing has always been the throughline, whatever the title on the door said."

Her work spans patient and clinician education, immunization and public health campaigns, mental health care communication, practice transformation, and health IT and telemedicine policy, developed for the New Jersey and Delaware Academies of Family Physicians, state health departments and independent healthcare clients. She now writes and designs independently as Stellar Blue. The design work is handmade, including patient education brochures, logos and print materials; see the design portfolio.

Patient Education Public Health & Immunization Practice Transformation Telemedicine & Health IT Mental Health Communication

A sample of clinical and public-health writing grouped by focus area. Full text is included where the piece is still Jay's to share; older or unlinked work is cited in full.

Independent Writing

1 entry
Stellar Blue2023
Probiotics: A Promising Treatment for 700 Million People Worldwide? Full text
A research-backed look at the gut-brain axis and emerging evidence on probiotics for PTSD, depression, and anxiety.
Read the article

Recently, I was alerted to a very interesting study by Dr. Shanlin Ke and team from the Harvard T.H Chan School of Public Health. The study, published in Nature Mental Health, looked into the possible effect a Mediterranean diet can have on the severity of symptoms of post-traumatic stress disorder (PTSD) in women.

The Gut-Brain Axis

In order to better understand how this is possible, we must look into how what we eat can affect how well we feel. The gut-brain axis, which has been talked about for quite some time, provides a communication pathway between emotion and cognition within the brain and gastrointestinal functions.1 More recently, research has begun to focus on the microbiota-gut-brain axis. This takes into account the microorganisms that live within and on our bodies, known as microbiota, as contributing factors in regulating gut-brain function. This modulation can be influenced by internal and external factors (e.g., diet, stress, environmental stressors) that can impact our ability to stay healthy.2

The Impact

The World Health Organization (WHO) estimates that 3.6% of the worldwide population has PTSD.3 PTSD affects some people who have experienced or witnessed one or more traumatic or terrifying event(s). The severity of symptoms varies and is not directly related to the level of violence in these events, but can be debilitating. In 2019, the WHO estimated that approximately 970 million people worldwide are dealing with some type of mental disorder.4 This worsened significantly in 2020, coinciding with the pandemic.5 Approximately 717 million of them are dealing specifically with depression, anxiety, and/or PTSD.3,4

Mediterranean vs. Other Diets

Dr. Ke and fellow researchers focused on the diet, stool sample findings, and reported symptoms of 191 women who were participating in a separate longitudinal study. The researchers found evidence demonstrating that the severity of PTSD symptoms was lessened in the cohort of women who followed a Mediterranean diet, compared to those who consumed more red and processed meats. The former had higher levels of a bacteria (Eubacterium eligens) that is linked to many of the components of a Mediterranean diet and found in much lower levels in the other proportion of the study population. The researchers of the study say that they will attempt to determine if probiotics can be used to prevent PTSD in future studies.

"In a future study, we will attempt to validate the efficacy of probiotics as a method to prevent PTSD."

Next Steps

Examples of the microbiota-gut-brain axis communication can be seen in something called dysbiosis — "an imbalance of the intestinal microbiota" with central nervous disorders, including depression and anxiety.6 If the research findings in Dr. Ke et al.'s study suggest that probiotics could prevent PTSD and the science links their findings to the improvement of symptoms in people suffering from PTSD, it warrants further investigation as to the possible inclusion of probiotics into the already available evidence-based therapies for not only PTSD but depression and anxiety as well.

This piece discusses PTSD, depression, and anxiety in a research context. If you're personally affected by any of these, the 988 Suicide & Crisis Lifeline (call or text 988) and SAMHSA's National Helpline (1-800-662-4357) are available 24/7.

References
  1. Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015 Apr-Jun;28(2):203-209. PMID: 25830558; PMCID: PMC4367209.
  2. Cryan JF, O'Riordan KJ, Cowan CSM, et al. The Microbiota-Gut-Brain Axis. Physiological Reviews. 2019;99(4):1877-2013. doi:https://doi.org/10.1152/physrev.00018.2018
  3. WHO. WHO releases guidance on mental health care after trauma. www.who.int. Published 2013. https://www.who.int/news/item/06-08-2013-who-releases-guidance-on-mental-health-care-after-trauma
  4. WHO. Mental disorders. www.who.int. Published June 8, 2022. https://www.who.int/news-room/fact-sheets/detail/mental-disorders
  5. World Health Organization. Mental Health and COVID-19: Early evidence of the pandemic's impact: Scientific brief, 2 March 2022. World Health Organization. Published March 2, 2022. https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci_Brief-Mental_health-2022.1
  6. DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current Understanding of Dysbiosis in Disease in Human and Animal Models. Inflammatory Bowel Diseases. 2016;22(5):1137-1150. doi:https://doi.org/10.1097/mib.0000000000000750

Patient Care & Mental Health

2 entries
Perspectives2017
Lessons From the Collaborative Full text
Practical communication techniques for primary care teams working with patients who have major depressive disorder.
Read the article

The Family Medicine Residency Program & Community Health Center Learning Collaborative has been coming together for over seven years to work on quality improvement projects. The Collaborative is currently working to improve the quality of care for patients with Major Depressive Disorder. One topic from the Collaborative's last learning session was interacting with depressed patients.

Between 20–22% of patients with depression receive treatment in the primary care setting,1,2 so it's important that the healthcare team knows how to interact with this population. It can be difficult or uncomfortable to interact with a patient suffering from depression, especially when a patient expresses suicidal ideation or begins to share excessive information during an intake interview.3

One method for mitigating difficult situations is adapting a guiding style of communication — a style between "directing" (providing information, advice, or instruction) and "following" (listening, seeking to understand, and refraining from offering personal opinion).4 This guiding style employs accurate empathy, using either simple reflection (paraphrasing back what the patient said) or complex reflection (adding substantial meaning or emphasis) to convey a deeper picture.5 Other methods include sitting with silence and using non-threatening words or phrases such as "stressed" or "overwhelmed" instead of "depressed," avoiding false reassurances (e.g., "It's going to be okay") and assumptions about the patient (e.g., "I imagine you must be feeling ____"), and not taking it personally if a patient lies or becomes irritable, as it isn't about them.3

When dealing with patients who overshare, use close-ended questions with only "yes" or "no" answers.3 A team member may interrupt a patient if they do so gently and respectfully — for example, by asking permission ("Can I interrupt you for a second?"). The best time to interrupt a patient telling their life story is when they take a breath.3 When speaking with patients who don't give enough information, ask open-ended or forced-choice questions, such as "People who feel down sometimes think they're a failure or they have let their family down. Do you ever feel that way?"3 Also, don't be afraid to sit in silence — a long silence is uncomfortable and will likely elicit a response from the patient.3

When dealing with patients who are depressed, it's important to always ask about suicide directly — 45% of individuals who died by suicide visited their primary care physician within one month of death.6 If patients are thinking about suicide, members of the healthcare team need to be comfortable talking about it, including being comfortable using the word "kill."3 Not asking about suicide reinforces the stigma associated with it.3 Patients with depression value how the healthcare team interacts with them: showing acceptance and interest, listening carefully, communicating clearly, collaborating on manageable goals, and advocating for greater patient self-compassion and self-care.7 These characteristics have resulted in positive outcomes in patients with depression.

This is a sensitive topic. If you or someone you know is struggling, the 988 Suicide & Crisis Lifeline (call or text 988) is available 24/7.

References
  1. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States. Archives of General Psychiatry. 2005;62(6):629-640.
  2. Uebelacker LA, Wang PS, Berglund P, Kessler RC. Clinical Differences Among Patients Treated for Mental Health Problems in General Medical and Specialty Mental Health Settings. General Hospital Psychiatry. 2006;28(5):387-395.
  3. Serine A. Communicating with Patients and Patients in Crisis. Paper presented at: MDD Learning Session 2; 2017; Exton, PA.
  4. Miller WR, Rollnick S. Conversations About Change. Motivational Interviewing: Helping People Change. 3rd ed. Guilford Press; 2013:4-5.
  5. Miller WR, Rollnick S. Evaluating Motivational Interviewing. Motivational Interviewing: Helping People Change. 3rd ed. Guilford Press; 2013:394.
  6. Luoma JB, Martin CE, Pearson JL. Contact With Mental Health and Primary Care Providers Before Suicide: A Review of the Evidence. Am J Psychiatry. 2002;159(6):909-916.
  7. Percival J, Donovan J, Kessler D, Turner K. 'She believed in me'. What patients with depression value in their relationship with practitioners. Health Expectations. 2017;20(1):85-97.
Perspectives2017
Beyond the Blues: Major Depressive Disorder Learning Session Recap Full text
A recap of NJAFP's annual Learning Collaborative session on major depressive disorder, including a Healthcare Theatre simulation on communicating with patients in crisis.
Read the article

One of NJAFP's quality improvement & education (QIE) projects is the Family Medicine Residency Program & Community Health Center Learning Collaborative. Every year, the Collaborative focuses on a different clinical indication. This year's indication is major depressive disorder (MDD). The Collaborative has been operating for seven years; recently moving from Pennsylvania to New Jersey. The Collaborative currently comprises nineteen practices (fifteen from Pennsylvania and four from New Jersey).

Participation in the Collaborative includes the submission of various data sets and participation in educational activities intended to positively impact how they screen for and treat MDD. The goal of the project is improvement in the diagnosis, management and outcomes of patients with MDD through comprehensive screening, treatment to remission, and behavioral health integration and care coordination within the medical neighborhood. The project is intended to improve the knowledge, confidence and performance of physicians and their care teams in the diagnosis, management and twelve-month outcomes of patients with MDD.

The curriculum is comprised of webinars and in-person Learning Sessions, as well as staff support and coaching. The kick-off for this year's MDD project was the Learning Session on April 20th and 21st, held at the Crowne Plaza in Reading, Pennsylvania. Sixty-five people attended the Learning Session, including physicians (52%), behavioral health providers (5%), nurses (7%), medical assistants (5%), front desk staff, and billing and office managers (9%).

The presentations covered several topics related to screening for and treatment of MDD. The Learning Session started with an optional Cognitive Behavioral Therapy (CBT) workshop held on Thursday evening, presented by Neil Skolnik, MD and Aaron Sutton, LCSW. Friday's plenary presentations included reviews of the Chronic Care Model (CCM) as it applies to depression treatment (Lee Radosh, MD, FAAFP, faculty); workflows for visits (also Dr. Radosh); proper empanelment of patients with MDD (Eric Gertner, MD, MPH, faculty); and a Plan-Do-Study-Act (PDSA) activity aimed at managing the MDD patient registry (Jorge Scheirer, MD, faculty).

The clinical breakout topics focused on the pathophysiology, etiology and clinical presentation of MDD (Gina Cavorsi, MD, Reading Health System [RHS]); pharmacologic & non-pharmacologic treatment options (Douglas Berne, MD, RHS); and a Healthcare Theatre simulation about managing side effects (facilitated by Amy Cowperthwait, MSN, BC-ACNS, University of Delaware's [UD] Healthcare Theatre). The non-clinical breakout topics included an overview of the various team member roles in the CCM for depression (Richard Hohner, LCSW, RHS); and a workshop and theatre simulation about communicating with depressed patients and patients who may be in crisis (Amelia Serine, MS, MS, Center for Brief Therapy, Philadelphia College of Osteopathic Medicine [PCOM] and facilitated by Allan Carlsen, UD Healthcare Theatre).

Highlights

One of the highlights of this Learning Session was the back-to-back non-clinical breakout sessions focused on communicating with depressed patients and patients who might be in crisis. The first part of the breakout was a workshop-style session given by Amelia Serine, MA, MS, a fifth-year doctoral student in the Clinical Psychology program at PCOM. Ms. Serine is also completing an American Psychological Association accredited pre-doctoral internship at the Center for Brief Therapy. She is trained in CBT, and has experience as a behavioral health consultant.

Ms. Serine's workshop was followed by a simulation performed by UD's Healthcare Theatre, provided by Theatre Director Allan Carlsen and two actors. Healthcare Theatre doesn't use scripts; they rely on the actors' improvisational abilities. Using a very different approach to education, "theatre students are trained to portray patients and family members so that [learners] can practice both technical and interpersonal skills in a safe environment without compromising quality of care" (http://www1.udel.edu/healthcaretheatre/).

Mr. Carlsen began the session by engaging the audience with questions related to the steps that lead up to screening a patient for depression. This technique ensured that he understood the practice roles of the learners, and that he could engage them throughout the simulation. Healthcare Theatre utilizes a "freeze frame" process, whereby throughout the simulation, the facilitator "freezes" the scene and asks the audience for feedback — for example, "How do you think this is going?" or "What would you do next?" — and then asks the learner to interact with the actor.

During one part of the simulation, one of the actors was portraying a very distraught patient. The learner checking her in was front desk staff. After interacting with the patient, her suggestion was that the patient needed someone to talk to right away rather than wait in the busy, public waiting room, and she wanted to be able to call a medical assistant or nurse to take the patient back to a room and wait with her. Collaborative faculty Dr. William Warning's response was that "each staff person in every practice should feel empowered enough to be clinical on some level, and we should have a culture in our practices that doesn't penalize staff for being patient-focused, even if that means their work gets delayed."

Mr. Carlsen and his team are very effective at creating a safe, interactive and improvisational environment for learners to test out ideas without fear of judgement from other learners. According to Healthcare Theatre, the "freeze frame" technique "allows providers to share best practice information and try different communication approaches in a safe practice setting." The result is a very intimate educational opportunity that is generally very well-received by the audience and successful at meeting the objectives for the learners, as demonstrated by feedback gathered from session evaluations. Overall, learners responded very positively to the Learning Session, with some attendees telling NJAFP staff that this was the best in the seven years they had participated.

For more information about the Collaborative, visit our website at http://njafp.org/content/tri-state-residency-collaborative, or contact the Program Manager directly.

The MDD initiative is funded by a grant from Takeda Pharmaceuticals, USA, Inc. and Lundbeck.

This piece discusses patients in mental health crisis. If you or someone you know is struggling, the 988 Suicide & Crisis Lifeline (call or text 988) is available 24/7.

Digital Health & Telemedicine

2 entries

Runyon pitched telehealth as an emerging topic to her editor in 2016, ahead of the regulatory and reimbursement shifts that would make it a mainstream primary care issue.

Perspectives2016
The Telemedicine Revolution Full text
An overview of telemedicine's regulatory landscape in New Jersey and its emerging role in primary care, written for the state academy's quarterly journal.
Read the article

Introduction

According to the American Telemedicine Association (ATA), more than 15 million Americans received remote medical care in 2015.1 While there are significant and reasonable concerns about the implementation and utilization of telemedicine, there are also potential benefits and, of course, hurdles to be overcome, practice standards and licensure portability being the biggest.2

Telemedicine in New Jersey

While New Jersey does not specifically authorize telemedicine in its statutes, existing physician licensing laws when applied to telemedicine require a physician be licensed in New Jersey prior to providing services to a patient in the state (N.J.S.A. § 45:9-6.).3 There are two minor exceptions to this rule (N.J.S.A. § 45:9-21). Subsection (c) of N.J.S.A. § 45:9-21 states a physician or surgeon of another US state who is authorized to practice medicine in that state, is not required to obtain a New Jersey license to practice telemedicine providing the practitioner does not open a practice in the state.3 N.J.A.C. §§ 13:35-7.1A and -7.5 also indirectly impact telemedicine by requiring all patients in the state to receive a physical exam before medication can be prescribed or dispensed.3 This regulation would limit telemedicine services, at least to the extent that drug therapy is included.3

Legislation to define telemedicine services are under consideration by the New Jersey Legislature (S291/A14644). According to New Jersey's pending legislation:

"Telemedicine" means the delivery of a health care service using electronic communications, information technology, or other electronic or technological means to bridge the gap between a health care provider who is located at a distant site and a patient who is located at an originating site, either with or without the assistance of an intervening health care provider, and in accordance with the provisions of this act. "Telemedicine" does not include the use, in isolation, of audio-only telephone conversation, electronic mail, instant messaging, phone text, or facsimile transmission (S291/A1464).

Broader Perspectives

The American Academy of Family Physicians' (AAFP) defines telemedicine as the "use of medical information that is exchanged from one site to another through electronic communications. It includes varying types of processes and services intended to enrich the delivery of medical care and improve the health status of patients."5

According to the AAFP processes and services can include activities such as subspecialists' consults where the subspecialist "sees" the patient in a live, remote visit or the transmission of video or diagnostic images for later review by the specialist.5 Also considered telemedicine is the use of electronic communication that is used to monitor patient vital signs remotely and then transmit them to the physician's office.5

Telemedicine in Primary Care

Telemedicine can complement primary care practice by allowing the primary care office to offer expanded services for non-emergency patients who need advice but not necessarily an office visit.6 The integration of telemedicine services into the primary care office has some promising benefits, though more studies are needed to determine its long-term impact. One thing is known, while telemedicine can be effective as face-to-face care, it will never replace the face-to-face visit.

Jessica Runyon is a program manager for the Healthcare Transformation and Quality Improvement program for the NJAFP.

References
  1. Beck M. How Telemedicine Is Transforming Health Care. Wall Street Journal. 2016. http://www.wsj.com/articles/how-telemedicine-is-transforming-health-care-1466993402.
  2. Thomas L, Capistrant G. 50 State Telemedicine Gaps Analysis Physician Practice Standards & Licensure. 2016.
  3. Hahn CK. Telemedicine and Beyond: The Current Status of the Law and Its Future. Focus. 2015;Summer:8-10.
  4. Assembly No. 1464. 2016; http://www.njleg.state.nj.us/2016/Bills/A1500/1464_I1.PDF.
  5. American Academy of Family Physicians. Telehealth. 2016; http://www.aafp.org/advocacy/informed/hit/telehealth.html.
  6. Crane M. Integrating telemedicine into your practice. Medical Economics. 2014. http://medicaleconomics.modernmedicine.com/medical-economics/content/tags/american-telemedicine-association/integrating-telemedicine-your-pract?page=full.
Unpublished2016
The Telemedicine Revolution (extended draft) Unpublished manuscript
A fuller, more heavily sourced draft of the piece above — covering CCHP telehealth policy tracking, JAMA Dermatology's findings on direct-to-consumer telemedicine, and clinical outcomes research on diabetes and cardiovascular care — prepared for the same issue but not run in this form.
Read the manuscript

Introduction

According to the American Telemedicine Association (ATA), more than 15 million Americans received remote medical care in 2015.1 While there are significant and reasonable concerns about the implementation and utilization of telemedicine, there are also potential benefits and, of course, hurdles to be overcome, practice standards and licensure portability being the biggest.2

Telemedicine in New Jersey

While New Jersey does not specifically authorize telemedicine in its statutes, existing physician licensing laws when applied to telemedicine require a physician be licensed in New Jersey prior to providing services to a patient in the state (N.J.S.A. § 45:9-6.).3 There are two minor exceptions to this rule (N.J.S.A. § 45:9-21). Subsection (c) of N.J.S.A. § 45:9-21 states a physician or surgeon of another US state who is authorized to practice medicine in that state, is not required to obtain a New Jersey license to practice telemedicine providing the practitioner does not open a practice in the state.3 N.J.A.C. §§ 13:35-7.1A and -7.5 also indirectly impact telemedicine by requiring all patients in the state to receive a physical exam before medication can be prescribed or dispensed.3 This regulation would limit telemedicine services, at least to the extent that drug therapy is included.3

Legislation to define telemedicine services are under consideration by the New Jersey Legislature (S291/A1464). According to New Jersey's pending legislation:

"Telemedicine" means the delivery of a health care service using electronic communications, information technology, or other electronic or technological means to bridge the gap between a health care provider who is located at a distant site and a patient who is located at an originating site, either with or without the assistance of an intervening health care provider, and in accordance with the provisions of this act. "Telemedicine" does not include the use, in isolation, of audio-only telephone conversation, electronic mail, instant messaging, phone text, or facsimile transmission (S291/A1464).

Broader Perspectives

The American Academy of Family Physicians' (AAFP) commentary on the subject provides a broader definition of telemedicine, stating:

Telemedicine is the use of medical information that is exchanged from one site to another through electronic communications" and "includes varying types of processes and services intended to enrich the delivery of medical care and improve the health status of patients.6

The AAFP also defines "telehealth," explaining that while telemedicine is a facet of telehealth, telehealth can include services that are not always considered clinical, such as a patient's use of a provider portal.6

Several other states have adopted guidelines for providing and receiving telehealth care, including laws that govern the legality and ethical standards involved in providing clinical services outside of one's state of licensure. For example, Delaware's Telemedicine Act (House Bill No. 69), enacted in July of last year, presents a very clear and well-defined set of rules for providing telemedicine services.7

State-specific telehealth-related legislation status can be accessed through the Center for Connected Health Policy (CCHP) website.8 CCHP is a "nonprofit, nonpartisan organization working to maximize telehealth's ability to improve health outcomes, care delivery, and cost effectiveness."9 CCHP played an integral part in the creation and adoption of the Telehealth Advancement Act of 2011.10 This act provided updated legal definitions, improved workflows for the delivery of telehealth services, and included a much broader scope of services under the telehealth umbrella.

Concerns

According to a study published in JAMA's Dermatology last month, telemedicine has many potential benefits, but still has a long way to go before it is ready for "prime time." Resnick et al. looked specifically at direct-to-consumer (DTC) telemedicine websites and smartphone apps for the purpose of diagnosing and treating skin disease.11 The study found that in 62 telemedicine encounters, 68% of patients were assigned to a physician without any choice; clinician credentials were disclosed a mere 26% of the time; only 32% of the clinicians discussed the possible side effects of the medications they were prescribing; and only 23% inquired about a patient's primary care physician. In addition, diagnostic performance was poor, with several major diagnoses being missed (e.g., secondary syphilis, eczema herpeticum, gram-negative folliculitis, and polycystic ovarian syndrome).11

However, changes are being made to improve telemedicine outcomes. For example, the American Medical Association (AMA) recently developed guidelines for ethical practice in telemedicine and the ATA is developing an accreditation program for online patient consults.12,13 The AAFP states that they are working with the House Energy and Commerce Committee and with individual lawmakers "who are developing proposals to enhance and expand the ability of family physicians to deliver telemedicine services to their patients."6 According to the AAFP, the Robert Graham Center held a multi-stakeholder symposium earlier this year. This meeting "brought together representatives of the physician, patient, academic and business community to discuss ways to improve the legal and regulatory framework of telemedicine."6

Benefits

According to Melinda Beck's article in the Wall Street Journal, of 2,033 adults polled online (Harris Poll, 2016), 61% said that they are open to using telehealth services and 16% had done so.1 Consumers reported the top benefits of telemedicine to be convenience (49%), cost savings (40%), ease of prescription refills (35%), and more frequent communication with a healthcare professional (26%).1

While many physicians are concerned about the breakdown of the doctor-patient relationship, there may be reason to believe that telehealth services could actually have the opposite effect when offered through a primary care provider's office, with the likelihood of improving access to and continuity of care. To this end, the AMA adopted a telemedicine policy to improve access to care for patients, which includes guidelines for the appropriate coverage of and payment for telemedicine services.12 AMA President Robert M. Wah, MD stated:

We believe that a patient-physician relationship must be established to ensure proper diagnoses and appropriate follow up care... This new policy establishes a foundation for physicians to utilize telemedicine to help maintain an ongoing relationship with their patients, and as a means to enhance follow-up care, better coordinate care and manage chronic conditions.12

In addition, there is the potential to provide care to patients in remote areas. For example, Mercy Health System developed a Virtual Care Center, described as "a 'hospital without beds' that provides remote support for intensive-care units, emergency rooms and other programs in 38 smaller hospitals from North Carolina to Oklahoma."1 Many of the facilities Mercy provides support to don't have a physician on-site 24/7. The outcomes of Mercy's Care Center are very promising: a 35% decrease in the average length of stay and 30% fewer deaths (1,000 people) than anticipated.1

Telehealth in Primary Care

How does telehealth fit into the structure and workflow of a primary care office? Mark Crane, in an article for Medical Economics, explained that telehealth:

…in primary care is used for a wide assortment of non-emergency problems for patients who want a doctor's advice but don't necessarily need to see him or her right away. Usually a phone call — although rapidly expanding to video conferences — telehealth doesn't replace face-to-face encounters with physicians. Instead, it can augment the doctor/patient relationship.14

Crane's article goes on to provide guidance on the planning for, and implementation of, integrated telehealth services in a primary care office, including some of the potential obstacles and pitfalls.14

Telehealth services have also been found to be as effective as face-to-face care, if not more so, in improving some patient outcomes. One study found that when compared to conventional care, telehealth services were more effective at improving treatment outcomes for patients with diabetes, particularly for those with type 2 diabetes.15 Another study delved into the impact that telehealth services could have on cardiovascular disease, and found a small clinical benefit for people with high cardiovascular risk, improvements in some risk behaviors, and improvements in patients' perceptions of support and access to care.16

Overall, while more studies are needed to evaluate the effectiveness of telemedicine services and their long-term impact on outcomes, the integration of telehealth services into primary care offers potentially promising benefits, at a relatively small expense and with minor adjustments to workflow and processes.

References
  1. Beck M. How Telemedicine Is Transforming Health Care. Wall Street Journal. 2016. http://www.wsj.com/articles/how-telemedicine-is-transforming-health-care-1466993402.
  2. Thomas L, Capistrant G. 50 State Telemedicine Gaps Analysis Physician Practice Standards & Licensure. 2016.
  3. Hahn CK. Telemedicine and Beyond: The Current Status of the Law and Its Future. Focus. 2015;Summer:8-10.
  4. Senate Bill No. 291. 2016 / Assembly No. 1464. 2016; http://www.njleg.state.nj.us/2016/Bills/A1500/1464_I1.PDF.
  5. American Academy of Family Physicians. Telehealth. 2016; http://www.aafp.org/advocacy/informed/hit/telehealth.html.
  6. House Bill No. 69. 2015; http://www.legis.delaware.gov/LIS/lis148.nsf/vwLegislation/HB+69/$file/legis.html?open.
  7. Center for Connected Health Policy. State Laws and Reimbursement Policies. 2016; http://cchpca.org/state-laws-and-reimbursement-policies.
  8. Center for Connected Health Policy. 2016; http://cchpca.org/.
  9. Center for Connected Health Policy. Telehealth Advancement Act. 2011; http://cchpca.org/telehealth-advancement-act.
  10. Resneck JS Jr, Abrouk M, Steuer M, et al. Choice, transparency, coordination, and quality among direct-to-consumer telemedicine websites and apps treating skin disease. JAMA Dermatology. 2016;152(7):768-775.
  11. AMA. AMA Adopts New Guidance for Ethical Practice in Telemedicine. 2016; http://www.ama-assn.org/ama/pub/news/news/2016/2016-06-13-new-ethical-guidance-telemedicine.page.
  12. Association AT. Accreditation Process. n.d.; http://www.americantelemed.org/accreditation/online-patient-consultations/accreditation-process.
  13. Crane M. Integrating telemedicine into your practice. Medical Economics. 2014. http://medicaleconomics.modernmedicine.com/medical-economics/content/tags/american-telemedicine-association/integrating-telemedicine-your-pract?page=full.
  14. Su D, Zhou J, Kelley MS, et al. Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract. 2016;116:136-148.
  15. Salisbury C, O'Cathain A, Thomas C, et al. Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial. BMJ. 2016;353(i2647):1-13.

Practice Transformation & Quality

2 entries
DelFamDoc2016
Practice Transformation: A Blueprint for Change Full text
A explainer on Delaware's State Innovation Model practice transformation project, written for primary care practices considering enrollment.
Read the article

The Delaware State Innovations Model (SIM) Practice Transformation Services project is well underway. The intent of this project is to raise the bar on health, and healthcare, throughout Delaware via the process of practice transformation. The main goals for this project (referred to as the Quadruple Aim) comprise better health, improved healthcare quality and patient experience, lower healthcare costs to all of Delaware's residents, and improved professional satisfaction levels for primary care physicians and other healthcare providers throughout the state.

Practices that enroll to receive free transformation services will achieve significant improvements in patient access to care and satisfaction levels; enhanced team-based care strategies; advances in population health and care management and planning; increased use of self-care for chronic condition management and techniques for fostering a relationship with community medical resources; and developments in performance measurement and quality improvement (QI) initiatives.

What is practice transformation?

Practice transformation can be defined in several ways; generally, the goals of transformation comprise developing a team-based care structure, a set of quality improvement standards to strive for, and a focus on patient engagement and satisfaction. For this project, DCHI defines transformation as "a high-level change in clinical and operational process to help you care for your entire panel of patients." The steps involved often focus on care management resources targeted to the highest-risk patients, transitional care planning, improving access to care, preventive care outreach, and the integration of behavioral health into the primary care setting. The guidelines and requirements for transformation vary by project, but are generally based on rapid change models and require practices to embed a culture of holistic change to succeed. For this project, successful practice transformation efforts — such as providing high-quality, patient-centered, cost-effective care — are tied to incentive payments.

Milestones have been developed to assist practices in defining their transformation goals and quality improvement initiatives. These milestones were created by the DCHI Project Team and will be used as benchmarks on the journey to practice transformation.

"We know how critical it is for you to have the tools you need to provide quality care in order for us to meet our goal to become one of the top five healthiest states in the nation. You have an opportunity to take part in a pioneering effort to make change possible."

What services are provided through this grant-funded project?

Primary care physicians interested in enrolling in this transformation project have a unique opportunity to receive expert transformation services from a resource they already know and trust. The New Jersey Academy of Family Physicians (NJAFP), in collaboration with the Delaware Academy of Family Physicians (DAFP), was recently awarded the role as vendor for Delaware's Practice Transformation Services Project.

In addition, the DAFP and NJAFP collaborative have an existing paradigm for mitigating the obstacles many primary care practices face when it comes to transformation:

  • The inherent lack of time and resources
  • Legitimate trepidations regarding the cost of health information technology (IT) services
  • Potentially limited resources with regard to collection and analysis of data
  • Difficulties in forecasting revenue stream in correlation to advances
  • Uncertainty about how effective QI changes will be in improving patient outcomes
  • Concerns about increases in workload and lack of overall patient benefit

Our services combine robust, accredited, evidence-based educational content with quality improvement science to guide primary care practices along the journey to population-level, value-based care. Our approach utilizes expert faculty to develop and teach clinically relevant educational curriculum, coupled with validated quality improvement survey tools, data review, and on-site interviews and observations to achieve each practice's improvement goals. Our team works with practices to develop a customized improvement plan and establish actionable steps that include an educational curriculum, targeted interventions, coaching recommendations, and community resources (e.g., hospitals, specialists, home health agencies) in order to achieve successful and sustainable outcomes. It is our goal to integrate continuing education for all eligible team members into each practice's QI efforts, in order to encourage the entire practice to embrace a culture of quality.

Resources

  • Practices interested in reading more about the DCHI's project can do so here: http://delfamdoc.org/DCHI-Practice-Transformation-FAQs.pdf.
  • Practices that would like to speak with one of our transformation experts about enrolling can call 302-733-3356, or submit their information here: https://www.surveymonkey.com/r/PTS_DE.

The issue closed with this note from DAFP Executive Director Raymond Saputelli: "The NJAFP and DAFP have the unique distinction of being solely dedicated to the success of family physicians and their patients. We are committed to ensuring that family physicians in Delaware are armed with the tools to deliver the value that they are uniquely suited to provide to their patients and the healthcare system." — Ray Saputelli, MBA, CAE

Sources
  1. Delaware Center for Health Innovation (DCHI, 2015). Retrieved December 10, 2015 from http://www.dehealthinnovation.org/Health-Innovation/Committees/Clinical-Committee/Practice-Transformation.
  2. American Academy of Family Physicians (AAFP; 2015). Survey: 1 in 3 Family Physicians Pursuing Value-based Payment. Retrieved December 09, 2015 from http://www.aafp.org/news/practice-professional-issues/vbpsurvey.html.
Perspectives2014
Avoiding the Rabbit Hole, or How Not to Get Lost in Your EHR Full text
A look at EHR documentation standards and patient-safety risk, prompted by a high-profile Ebola case involving a documentation breakdown.
Read the article

We have all heard by now that the electronic health record (EHR) system by Texas Health Resources (THR) was not at fault when Texas Health Presbyterian Hospital in Dallas sent Thomas Eric Duncan home after he admitted to visiting Liberia, complained of symptoms that could be caused by the Ebola virus, and admitted to having been in contact with infected individuals. Mr. Duncan died from the virus ten days after his first visit to the Dallas emergency department.

After the hospital initially issued a statement saying that "a flaw in the interaction between the physician and nursing portion of the EHR caused the patient's travel history to not appear in the physician's standard workflow," THR issued a correction two days later stating that the EHR was not to blame, but hasn't elaborated any further.

Despite the lack of EHR culpability in this unfortunate situation, the controversy reopens a necessary dialogue about the importance of setting up an EHR system carefully, and the necessity of regular reviews and maintenance. This highlights a very important piece of the documentation process — and one that NJAFP stresses to the practices it works with: the need to establish, in advance, a set of standard operating procedures (SOPs) for EHR documentation that are easily accessible as a resource for all staff, and are included in all EHR-related training.

EHR systems can provide significant flexibility for a practice, and while this allows practices to model these systems according to their needs, it also creates a conundrum — sometimes, too many options can lead to chaos. An example can be made with immunization documentation: a patient's immunization history can be documented in a health maintenance tab, an immunization log, in a patient's history, or in a doctor's or nurse's notes. If the practice doesn't have a uniform plan in place for where staff should be documenting this information, then team members who need to review or retrieve it — or those responsible for generating reports from the EHR system — may not be querying the right location, or the documentation may not be retrievable at all. NJAFP Project Facilitator Tara Perrone, MHA, states that "oftentimes, practices document in locations of the system that are not part of a 'structured data field' and the data cannot be extracted at all." So unfortunately, even with the best of intentions and resources, it's possible to set up a personalized, working EHR structure and not notice the potential for loopholes and cracks.

Hardeep Singh, a researcher at the Michael E. DeBakey VA Medical Center's Center for Innovations in Quality, Effectiveness and Safety, and recent EHR study coauthor,1 put it plainly: "People are mostly working to meet the federal requirements and not paying as much attention to the patient safety issues." In a related article, Singh and colleagues recognize that "EHR-related errors are complex, and the roots of these errors are often multifaceted. Risks for EHR-related errors and breakdowns may be related to features of the technology itself, user behaviors, and organizational influences on how the EHR is routinely used, maintained, and monitored."2

In response to these concerns, Singh and colleagues developed the Safety Assurance Factors for EHR Resilience (SAFER) Guides, designed to help healthcare organizations conduct self-assessments to optimize the safety and safe use of EHRs3 across a variety of areas, including a checklist of recommended practices, downloadable reference materials, practice worksheets, assessment resources, and follow-up tools. According to the SAFER website, the guides are designed in part to help deal with safety concerns created by the continuously changing landscape that healthcare organizations face — and, while following the guidelines doesn't guarantee legal compliance, periodic self-assessments can help identify areas where changes need to be made for the safe use of EHRs.

One of the areas covered by the SAFER Guides is Clinician Communication.4 The Guide stresses the importance of this communication and the possible ramifications of a communication breakdown. Tying this back to the controversy in Texas, SAFER notes that "several attributes of EHR-based communication can result in a disconnect between the sender and the receiver of clinical information." The Clinician Communication Guide stresses the importance of establishing SOPs and following protocols, but also allows for an evolving system — ideally leading to a consensus about an organization's future path to optimize EHR-related safety and quality.

When working with practices and clients, NJAFP has always strongly recommended the development and adoption of guidelines and SOPs to ensure regular monitoring of EHR documentation by care team members, with monitoring performed at a regularly defined interval and results reported back to leadership.

References
  1. Rice S. Complicated, confusing EHRs pose serious patient safety threats. J Amer Med Informatics Assoc. http://www.modernhealthcare.com/article/20140620/NEWS/306209940/complicated-confusing-ehrs-pose-serious-patient-safety-threats. Published June 20, 2014. Accessed October 16, 2014.
  2. Singh H, Ash J, Sittig D. Safety Assurance Factors for Electronic Health Record Resilience (SAFER): study protocol. BMC Medical Informatics and Decision Making 2013, 13:46. doi:10.1186/1472-6947-13-46. Published April 12, 2013. Accessed October 16, 2014.
  3. Health IT.gov SAFER Guides. SAFER Self Assessment; System Configuration. http://www.healthit.gov/sites/safer/files/guides/safer_systemconfiguration_sg004_form_0.pdf Published January 2014. Accessed October 16, 2014.
  4. Health IT.gov. SAFER Guides. Self Assessment; Clinical Communication. http://www.healthit.gov/sites/safer/files/guides/safer_cliniciancommunication_sg009_form.pdf. Published January 2014. Accessed October 16, 2014.

Public Health & Immunization

1 entry
NJDOH2015
Adolescent Influenza Immunization Full text
A herd-immunity explainer and practical toolkit for family physicians working to raise adolescent flu vaccination rates.
Read the article

This article was funded by a grant from the NJ Department of Health's Vaccine Preventable Disease Program.

Flu season is the perfect time to review the importance of complying with the recommended vaccination schedules for adolescents. While the rate for flu-related hospitalizations in the 5–17-year-old population varies each year - the 2012-2013 flu season resulted in 14.6 hospitalizations per 100,000 individuals, dropped to 9.4 hospitalizations per 100,000 in the 2013-2014 season and rose 16.7 per 100,000 in the 2014-2015 flu season – immunization for adolescents is the best way to keep these numbers down (CDC, 2015b). In addition to the infection and hospitalization rates for adolescents, it is important to consider the impact that adolescent vaccinations have on the community as a whole.

Last season's influenza impact report helps to shed some light on this point. The CDC reported that in February of 2015 hospitalizations for flu-infected people 65 years of age and older was the highest recorded rate since the CDC began tracking that statistic in 2005 (CDC, 2015d). A staggering 60% of flu-associated hospitalizations were attributed to this population (CDC, 2015d). The second highest hospitalization rate was seen in children age ≤ 4 years. Hospitalized adolescents range between these two extremes. These statistics bring up an important question - how many people have to be vaccinated to generate a marked decline in the rate of infection and therefore the number of flu-related complications?

To answer that question it is necessary to understand "herd effect" and "herd immunity threshold" as it relates to immunization and indirect protection from infection. "Herd effect" reflects the result of an algorithm based on standard infection rate assumptions when applied to immunization. Transmission of a communicable disease follows a predictable pattern (when transmission is introduced into a totally susceptible population) of one case leading to four cases, which leads to 16 cases, and so on (Fine, Eames, & Heymann, 2011). However, if 75% of the population is made immune, each case only leads to one transmission of the infection – a progression which can be sustained over time provided the same proportion of the population remains immune (Fine et al., 2011). Understandably, if a greater proportion of the population is immunized, the incidence of infection will decline. The percentage of individuals required to effectively achieve this decline in incidence is referred to as the "herd immunity threshold" (Fine et al., 2011). While the terms "herd effect" and "herd immunity threshold" are unlikely to motivate most parents and/or adolescents to follow the recommended vaccination schedules, this effect is the justification for just how important proper immunization is.

In order to reach the herd immunity threshold for influenza in the United States, 80% of healthy individuals and 90% of the high-risk population would need to be vaccinated against influenza (Plans-Rubió, 2012). However, the current vaccination rate for influenza in the United States is only 47.1% (CDC, 2015a). The CDC recommends that everyone over the age of six months (who do not have contraindications) should receive the influenza vaccine annually (CDC, 2015a) but vaccination coverage records for the 2014-2015 season showed a decrease in adolescent vaccinations with a correlative increase in age – 61.8% of eligible 5–12-year-olds received the flu vaccine, but only 46.6% of eligible 13–17-year-olds were vaccinated (CDC, 2015a).

Vaccination is not only a valuable means of protecting the individual, it also offers indirect protection for those who may be susceptible to the disease, but are not or cannot be vaccinated, as well as those at risk for developing complications from infection (e.g., pneumonia, bronchitis, death). The populations at highest risk for developing flu-related complications are children younger than two years old, adults 65 years of age and older, pregnant women, residents of nursing homes and other long-term care facilities, American Indians and Alaskan Natives, and those with certain medical conditions (CDC, 2015c). While it is true that most teens or preteens who get the flu will recover, others will go on to develop complications such as pneumonia or sinus infections (CDC, 2014). Adolescents with chronic diseases such as asthma or diabetes are at an even greater risk for flu complications (CDC, 2014).

Family physicians are crucial to achieving the herd immunity threshold required to effectively decrease the incidence and impact of influenza, but increasing the rate of adolescent influenza vaccination poses a challenge for many clinicians. While patient and parental education can be provided through office brochures, posters and discussions during office visits, increasing the rate of immunization to a more effective level may require additional steps, such as:

  • Offering walk-in hours solely for vaccination purposes so parents don't have to fit an office visit into an already hectic schedule
  • Leveraging existing social media platforms and/or patient portals to educate patients (and the community) about the importance of immunization, as well as providing reminders of the vaccination recommendations for adolescents and the office's availability to provide those vaccinations
  • Coordinating with the local middle schools and parent groups (e.g., the PTA) to offer brief informative sessions for medical staff, parents and students
  • Offering to host flu clinics at local schools (contingent upon parental consent)

Additional information on adolescent vaccination schedules and related information can be found using the following links:

  • Information for Healthcare Professionals about Adolescent Vaccines
  • Birth-18 Years & "Catch-up" Immunization Schedules
  • Patient and Parent Handout: Immunization Schedules for Preteens and Teens
  • Current Influenza ACIP Vaccine Recommendations
  • http://www.cdc.gov/vaccines/who/teens/downloads/hcp-factsheet.pdf
References
  1. CDC. (2014). Flu vaccine for preteens and teens. Preteen and Teen Vaccines. Retrieved October, 2015, from http://www.cdc.gov/vaccines/who/teens/vaccines/flu.html
  2. CDC. (2015a). Flu coverage, United States, 2014-15 Influenza Season. Seasonal Influenza (Flu); FluVaxView Influenza; Vaccination Coverage 2014-15 Flu Season. Retrieved October, 2015, from http://www.cdc.gov/flu/fluvaxview/coverage-1415estimates.htm
  3. CDC. (2015b). Laboratory-confirmed influenza hospitalizations. FluView. Retrieved October, 2015, from http://gis.cdc.gov/GRASP/Fluview/FluHospRates.html
  4. CDC. (2015c). People at high risk for developing flu-related complications. Influenza (Flu). Retrieved October, 2015, from http://www.cdc.gov/flu/about/disease/high_risk.htm
  5. CDC. (2015d). What you should know for the 2014-2015 influenza season. Influenza (Flu). Retrieved October, 2015, from http://www.cdc.gov/flu/about/season/flu-season-2014-2015.htm
  6. Fine, P., Eames, K., & Heymann, D. L. (2011). "Herd immunity": A rough guide. Clinical Infectious Diseases, 52(7), 911-916. doi: 10.1093/cid/cir007
  7. Plans-Rubió, P. (2012). The vaccination coverage required to establish herd immunity against influenza viruses. Preventive Medicine, 55, 72-77. doi: 10.1016/j.ypmed.2012.02.015

Clinical Research

1 entry
Sleep Review2001
Gender Differences in Symptoms Associated with Sleep Apnea Full text
An analysis of questionnaire data from 2,757 patients referred for polysomnography, showing that women and men report sleep apnea symptoms differently and that these differences may contribute to underdiagnosis in women.
Read the article

A study at the Penn Center for Sleep Disorders showed significant differences in the way men and women report symptoms of sleep apnea by using various methods of measurement.

The study of gender differences in sleep apnea is a new and important area. We at the Penn Center for Sleep Disorders at the University of Pennsylvania Medical Center, Philadelphia, believe that women and men exhibit different symptoms associated with sleep apnea. It is also possible that certain symptoms of apnea are more important in women than men, and that these symptoms may confound the diagnostic process. This may help to explain why sleep apnea is still relatively underdiagnosed in females as compared to males.1

Pillar et al2 demonstrated a difference in the presentation of sleep apnea symptoms among men and women. These subjects were all referred for polysomnography. Men reported excessive daytime sleepiness symptoms (including daytime fatigue and tiredness) as most significant. Women, on the other hand, reported more symptoms of fatigue, insomnia, tension, and the use of sedatives. Therefore, it is understandable that women who have sleep apnea may be misdiagnosed with depression, a disorder that shares many of the same symptoms as the women described in Pillar’s study.2 This is especially true if such women do not complain of snoring or other classic apneic symptoms. Young and associates3 found that women reported more morning headaches, while men concentrated on classic symptoms of apnea including snoring, snorting, and gasping for breath.

Our hypothesis was that there would be significant differences in the way that men and women reported symptoms of apnea if they were studied using several reliable methods of measurement. Pillar and Young’s data2,3 support such a hypothesis. We hypothesized that men would complain of more snoring, snorting, and other classic symptoms of apnea while women would complain of more daytime sleepiness and dysfunction, difficulty sleeping, and sleep disturbances.

The Study

Data were collected from 2,757 subjects, all of who were referred for polysomnography testing at the Penn Center for Sleep Disorders. Subjects consisted of 1,799 men with a mean age of 49 ± 13.40 and 958 women with a mean age of 48 ± 14.13. Due to missing data, only 1,672 observations can be used. The mean body mass indexes (BMI=kg/m2) for men and women were 32 ± 7.77 and 35 ± 11.00, respectively. There was a total of 1,933 Caucasian subjects (male N=1,383, female N=550), 713 African-American subjects (male N=347, female N=366), 46 Asian subjects (male N=31, female N=15), 34 Hispanic subjects (male N=22, female N=12), two American Indian subjects (male N=1, female N=1) and 29 subjects classified as “Other” (male N=15, female N=14). All of the subjects were asked to fill out the same questionnaires: The Multi-Variable Apnea Sleep Symptom Frequency Questionnaire (MAP),4 the Epworth Sleepiness Scale (ESS),5 and the Pittsburgh Sleep Quality Index (PSQI)6 (Tables 1-3).

After the patients underwent polysomnography tests and their diagnoses were established, they were separated by severity of respiratory disturbance index (RDI) for analysis. There were four groups of RDI levels: <5 (normals); <15 (mild apnea); 15-30 (moderate apnea); and >30 (severe apnea). Subjects were also separated by gender.

MAP I1ApneaSnorting, or gasping; breathing stops, loud snoring
MAP I2Difficulty SleepingFrequent awakenings; tossing, turning; morning headaches
MAP I3Daytime SleepinessFalling asleep at work or while driving; excessive daytime sleepiness
MAP I4Narcolepsy-like SymptomsAwaken feeling paralyzed; vivid dream-like state while falling asleep or awakening
Table 1. Multi-Variable Sleep Symptom Frequency Questionnaire.
SituationScore
Sitting and reading
Passenger in a car
Lying down to rest in the afternoon
Sitting and talking to someone
Sitting after lunch without alcohol
In a car, stopped for a few minutes in traffic
Total (Normal < 10)
Table 2. Epworth Sleepiness Scale.
PSQI 1Subjective Sleep QualityRating Sleep Quality
PSQI 2Sleep LatencyLength of time it takes to fall asleep
PSQI 3Sleep DurationHours of sleep time
PSQI 4Habitual Sleep EfficiencyNumber of hours slept/number of hours spent in bed x 100 = %
PSQI 5Sleep DisturbancesGetting up while sleeping; cannot breathe; bad dreams; pain
PSQI 6Use of Sleep MedicationFrequency of use
PSQI 7Daytime DysfunctionDifficulty staying awake while driving; maintaining enthusiasm
Table 3. Pittsburgh Sleep Quality Index.

Multi-Variable Apnea Sleep Symptom Frequency Questionnaire

All subjects filled out the MAP, designed by the Center for Sleep Disorders at the University of Pennsylvania Medical Center as a screening tool for sleep apnea based on the reporting of various symptoms of sleep apnea and other sleep disorders plus age, body mass index, and gender.4 The MAP variables focus on typical symptoms of apnea including snoring, snorting, difficulty sleeping, and daytime sleepiness (Table 1).

MAP I1

The first variable, MAP I1, is a measure of traditional apneic symptoms: apneas, snoring, and snorting. In our study, there were no significant differences between the way that women and men answered this question, but the results were found to be dependent on RDI. A linear trend was found showing that as severity of apnea increased, so did the frequency and severity of these symptoms (Figure 1).

Line graph of MAP I1 scores by RDI group for men and women. Scores rise from about 1.8 at RDI 0 to under 5 to about 2.9 at RDI 30 or higher, with nearly identical lines for both genders.
Figure 1. MAP I1.

MAP I2

In the second variable, MAP I2, there were significant differences in the way that women answered these questions. This variable examines difficulty sleeping—specifically, frequent awakenings; tossing, turning, or thrashing; difficulty falling asleep; legs feeling jumpy or jerky; and morning headaches. While the results were not dependent on RDI severity, women had a significantly higher score on this question than men (P<0.05). So, while male and female normals had no significant difference in score (the same at all RDI levels), the answers of men and women in general showed a difference (Figure 2).

Line graph of MAP I2 scores by RDI group. Women score about 2.0 to 2.1 across all RDI groups and men score about 1.55 to 1.65, with little change by severity.
Figure 2. MAP I2.

MAP I3

Answers in the third MAP variable (MAP I3) were not significantly different between genders. The measurement of daytime sleepiness (falling asleep when at work or school, falling asleep when driving, and excessive sleepiness during the day) did not demonstrate gender-related differences, but there were differences associated with RDI severity. The trend showed a steady increase in scores as apneic severity increased (with a small drop for women between the <5 – >5 group), and then a large jump for the severe apneic group (Figure 3).

Line graph of MAP I3 scores by RDI group. Both genders rise to about 1.7 at RDI 30 or higher; women dip from about 1.5 to 1.3 between the first two groups.
Figure 3. MAP I3.

Epworth Sleepiness Scale

The second method of measurement was the ESS, a self-administered eight-item questionnaire. The ESS has been proven to be a simple and reliable measure of daytime sleepiness in adults.5 The ESS asks the patient to rate their likelihood of falling asleep at a given time. The scale is 0-3: 0=never, 3=always (Table 2).

Our data found that severity of apnea had the greatest correlation with the ESS measure of overall sleepiness in adults. Results showed that as RDI increased, so did overall sleepiness. Gender had no significant impact on these symptoms.

Pittsburgh Sleep Quality Index

The third questionnaire used as a measure was the PSQI. The PSQI is designed to measure sleep quality and disturbance retrospectively over a month period using a self-report method.6 The PSQI has served as a measure of subjective sleep quality in elderly and psychiatric patients and has seven main variables (Table 3).7,8 All of the PSQI variables showed significant differences in the scores between men and women (P<0.05) (Figure 4).

Line graph of scores on PSQI variables 1 through 7 for men and women. Women score higher than men on every variable, with the widest gaps on PSQI 2 and PSQI 4.
Figure 4. PSQI Gender Differences.

In the PSQI 1, women had significantly higher scores than men (P<0.05). This measure would mean that women rated their overall sleep quality as better. Significant differences among RDI levels were also found (P<0.05). While scores increased across levels of RDI from mild to severe apnea, normals had a higher score than all other groups indicating that they thought they had the best sleep quality.

On variable PSQI 2, a measure of sleep latency, women scored significantly higher than men (P<0.05). These differences indicate that women take a longer time to fall asleep than men. However, based on the scores from PSQI 3, a measure of sleep duration, women actually thought that they slept significantly longer than men (P<0.05).

On the PSQI 4, which measures sleep efficiency (time spent in bed/time spent sleeping), women scored significantly higher than men (P<0.05). This is consistent with the earlier finding that women consider their sleep to be of better quality than men. We also measured the frequency and severity of sleep disturbances on the PSQI 5. Women scored significantly higher than men (P<0.05) on this variable. Although women reported significantly worse sleep disturbances, they actually thought that their sleep was of significantly higher quality.

When measuring the use of sleeping medications (PSQI 6), women scored significantly higher than men. It is also interesting to note that use of sleeping medications differed significantly between RDI levels (P<0.05). Subjects considered normals (RDI < 5) used significantly more sleeping medications than all apneic subjects, and apneics in the mild (RDI 5-15) category used sleeping medications more frequently than moderate (RDI 15-30) and severe (RDI > 30) apneics. The severe apneics used significantly more sleeping medications than moderate apneics (P<0.05). The interaction between gender and RDI also proved to be significant (P<0.05). These data indicate that the frequency of use of sleeping medication increased across RDI levels, and was greater in females, and there was also a significant difference between the use of sleeping medications among men and women within each RDI category (P<0.05). Normal women used more sedatives than normal men. Mildly apneic women used more sleeping medications than men of the same category. Moderately apneic men used more sleeping medications than moderately apneic women, and women with severe apnea had a higher instance of use than males with severe apnea. Again, as stated earlier, normals of both genders used sleeping medications more frequently than men and women in all other categories.

On variable PSQI 7, which measures daytime dysfunction, women noted that their symptoms were significantly worse than men (P<0.05), suggesting that even though their sleep quality was good, it may not be good enough.

Findings

There are a number of important findings in this study. First and foremost, the prevalence of significantly higher scores of apneic symptoms for women than men demonstrate that women do experience certain symptoms of apnea differently than men. The data from Pillar et al2 support these findings. They demonstrated gender-specific symptom profiles of women with suspected apnea. Women complained more of fatigue and consumed more sleeping pills. Their findings also were independent of the level of apnea and were most likely more related to environmental factors. Millman et al9 found a relationship between patients diagnosed with apnea and depression. Forty-five percent of the apneic patients interviewed were depressed according to a self-report questionnaire. Considering similarities between the symptoms associated with depression and sleep apnea (fatigue, lack of motivation, and loss of vital energy), this is not surprising. Eleven of these patients who were treated with continuous positive airway pressure (CPAP) no longer fit the DSM-IV criteria for depression.

Conclusion

When separating the subjects by gender, women reported more difficulty sleeping on the MAP and PSQI; longer sleep latency and duration as well as better sleep efficiency on the PSQI; and greater sleep disturbances on the MAP and PSQI. Women and men demonstrated no differences in excessive daytime sleepiness (EDS). However, women had higher scores on some symptoms associated with EDS, such as maintaining enthusiasm. When separated by severity of apnea, classic apnea symptoms increased across all levels of RDI breakdown, as well as sleep disturbances and daytime sleepiness.

Gender differences in apnea symptoms require further research. Studies need to focus on the effect of socioeconomic status and ethnicity in the presentation of sleep apnea. Quality of life measures associated with sleep apnea need to be examined for possible gender bias and modifications need to be made in the screening tools for apnea since our data demonstrate that women with sleep apnea respond differently than men. In addition, there may be differences in the anatomical structure of the upper airway of men and women, which could affect the diagnosis of this very common disorder.

Jessica J. Runyon is clinical research coordinator; Greg Maislin, MA, MS, is director of biostatistical core; and Richard J. Schwab, MD, is director of medicine and assistant professor, all at the Penn Center for Sleep Disorders, Philadelphia.

References
  1. Schwab RJ. Sex differences and sleep apnoea. Thorax. 1999;54:284-285.
  2. Pillar G, Lavie P. Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest. 1998;114:697-703.
  3. Young T, Hutton R, Finn L, Badr S, Palta M. The gender bias in sleep apnea diagnosis: are women missed because they have different symptoms? Arch Intern Med. 1996;156:2445-2451.
  4. Maislin G, Pack A, Kribbs N, et al. A survey screen for prediction of apnea. Sleep. 1995;18:158-166.
  5. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15:376-381.
  6. Buysse DJ, Reynolds C III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193-213.
  7. Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 1998;45:5-13.
  8. Gentili A, Weiner DK, Kuchibhatla M, Edinger JD. Test-retest reliability of the Pittsburgh sleep quality index in nursing home residents [letter]. J Am Geriatr Soc. 1995;43:1317-1318.
  9. Millman RP, Fogel BS, McNamara ME, Carlisle CC. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry. 1990;51:309-310.

Patient-Facing Materials & Design

2 entries
HUPn.d.
Advanced Breast Imaging (ABI) Patient Recruitment Brochure Writing & design
A patient-facing brochure written and designed to recruit participants for breast imaging research studies (digital mammography, ultrasound, MRI, and PET), explaining eligibility and each imaging method in plain language.
NJAFPn.d.
Managing Triggers When You Have Allergic Asthma Writing & design
A patient education brochure written and designed to help people with allergic asthma recognize common triggers and reduce them at home. The inside panels turn trigger control into a checklist of daily, weekly and monthly tasks, and the outside panels guide patients to discuss their triggers and treatment goals with their primary care physician.

Additional Work

2 citations
  • Runyon J, Barrett TJ. HPV Immunization. Your Academy in Action. November 2015.
  • Runyon J, Barrett TJ. Maintaining Adolescent Health (Parts 1 & 2). Your Academy in Action. October–November 2015.